Résumé : Accurate cancer risk estimation is crucial to clinical decision-making, such as identifying high-risk people for screening. However, most existing cancer risk models incorporate data from epidemiologic studies, which usually cannot represent the target population. While population-based health surveys are ideal for making inference to the target population, they typically do not collect time-to-cancer incidence data. Instead, time-to-cancer specific mortality is often readily available on surveys via linkage to vital statistics. We develop calibrated pseudoweighting methods that integrate individual-level data from a cohort and a survey, and summary statistics of cancer incidence from national cancer registries. By leveraging individual-level cancer mortality data in the survey, the proposed methods impute time-to-cancer incidence for survey sample individuals and use survey calibration with auxiliary variables of influence functions generated from Cox regression to improve robustness and efficiency of the inverse-propensity pseudoweighting method in estimating pure risks. We develop a lung cancer incidence pure risk model from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial using our proposed methods by integrating data from the National Health Interview Survey (NHIS) and cancer registries.